-1.14%237,250-1.14%:239,980:239,980:240,330:234,110:11,443,769 : , . -20% -2.48 -2.06 . -6.8% -183.7 -172 . -EBITDA -34.5% -184.3 137 . -55.5 , 30% -42.7 2020. -9 7.72 2020. , . . -13.8% -739 … [+202 chars]
46% 2021 -140 -2020. 46% -2021. : " " " ( ) () 2021 . ", 2021 -1.09 1.227 2020. 354 243 2020. 46%. -26% -127 100 2020. 2021, 302 555.9 . , 379 -2020 681.7 . 2021 1.840 ( ") - 1.798 ( ") . … [+56 chars]
NucleAI , (') 33 , Section32, , '. , : Debiopharm, Fosun RZ Capital, Vertex Ventures Israel, Grove Ventures . -50 . . , , , , . , , , , , . . -Nucleai . , , . , . , . -2018 , , . , " 60 . . " … [+37 chars]
" +2.02%14,660+2.02%:14,370:14,360:14,730:14,320:3,171,725 : -12 -46% " -13%, " 90, . , " - . ( ) . . 30% 14% . -243 370 . 46% -354 , -26% -127 , 100 2020. 30% , , ? : 14% -157 , 137 . 175… [+145 chars]
- 31.12.2021 2021, -14 " 0.13 " . 2021: 2021 - 85.7 ", - 77.5 " , - 11%. - 36.6 ", , . , . , - 17.4 " - 14% 2020. - 17.6 " - 13.5 ". 2021 - 68.6 " - 63.7 ", - 8%. (- 7% ). 2021 - 1.3 " , - 1.… [+144 chars]
-0.49%10,200-0.49%:10,250:10,250:10,260:10,080:323,541 : -IT . . -2.5% -670 -652 . , , , . () -8%, -3.6%, , -5.8%. . -8% -91 84.2 . 9 . -EBITDA -9% -74.6 68.4 . -46% -13.3 24.8 . -1.5% -2.26… [+122 chars]
? ' ' - : 119.8 (') -3.49 - -72.2% 2020. ( ) -34.3, - -36.4. " " -2.23 2021 -61.2 . , -38.2% 2020. , -82.8% , -67.3 , -5.9 2021 - -68.6%. , . , - 32.1%, -69.9 , -17.4% , -168 . -2 2021, , , . … [+2 chars]
, , -10 . , , , . : " , - . , , ". , " : " , , , . , , , . . , , ".
(') , -20 6.3 . -40% . -17%. ' -40 , " . , " . , - , . -10 . ... <ol><li></li></ol><ol><li></li></ol><ol></ol>
| , Investing.com | (TASE:SAE) 2021, , , . -3.6 , -6.7% 2020. -100 , -17% -120 2020. PayBox. , 3.1% -14.8 , 2% -393 . -0.5% , 11.6% -7.6 . -4.02 , 27.2% , -4.04 , -26.5% . . -… [+304 chars]
, , , . (B2B), . , (Priority), , . , - , , , , – . , . , , . , , . , , , , , , . . : , . , , . , , , . . , , ' . , , . . , . , , . , , , , . , . : , , : " , , , , . , , ". , " , … [+22 chars]
- (Capitolis) () 110 , 1.6 . . ', 9 -SVB , , , , S , ', . , , 280 . . " , , : ... <ol><li></li></ol><ol><li></li></ol><ol></ol>